Navigation Links
Additional Data From Multiple Phase 1 and 2 Studies of S*BIO's Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis (MF)
Date:6/1/2011

SINGAPORE, June 1, 2011 /PRNewswire/ -- S*BIO Pte Ltd today announced that additional data from multiple Phase 1 and 2 clinical studies of its novel JAK2 inhibitor SB1518 further confirmed safety and efficacy for the treatment of patients with symptomatic myelofibrosis (MF) and enlarged spleens. In the studies, SB1518 alleviated MF-associated splenomegaly and showed no evidence of myelosuppression and no exacerbation of cytopenias. Results will be presented at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago and the 16th Congress of the European Hematology Association (EHA) in London.

"Data pooled from the two Phase 1 trials demonstrate sustained clinical benefit in MF patients when treated with SB1518," said John Seymour, Head of the Department of Haematology at the Peter MacCallum Cancer Centre, Melbourne, "The once-daily dosing was well tolerated for over 2 years in on-going patients with no long-term toxicities observed."

Ruben A. Mesa, M.D., principal investigator at Mayo Clinic, said, "The new data from the Phase 2 study clearly showed durable responses in both spleen volume reduction and in relieving MF related symptoms. More importantly, these treatment effects were observed in MF patients with significantly impaired hematopoiesis without further exacerbating cytopenias. These results show that treatment with SB1518 is particularly important for MF patients with impaired hematopoiesis. The side effects were generally low grade, easily manageable and there were no discontinuations due to GI toxicities."

Dr. Jan-Anders Karlsson, CEO of S*BIO, added, "The data are further evidence that SB1518 is safe, effective and well tolerated in MF patients including those who present with severe splenomegaly.  The convenient once daily dose was well tolerated with manageable side effects across all studies. In light of these positive and encouraging results, we are rapidly advancing our JAK2 inhibitor through lat
'/>"/>

SOURCE S*BIO Pte Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity
2. Hope Paige Designs Medical ID Bracelets Now Available in 1,100 Additional Locations
3. Ardea Biosciences Provides Additional Results From a Phase 2b Study of Lesinurad in Combination With Allopurinol at the Annual European Congress of Rheumatology
4. Omeros Reports Allowance of Additional Patent for Arthroscopic Product
5. Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations
6. Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
7. Rosetta Genomics Announces Issuance of Additional U.S. Patent
8. HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients
9. Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck
10. Southern Home Medical Equipment Reports Additional Revenues and Profits for 2010
11. Additional 8 Products of DK Sinopharma, Inc. are Included in 2010 Provincial Medical Insurance Catalogs in 4 Separate Provinces in the Peoples Republic of China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... lot of discussion in the medical community revolves around figuring ... conditions. As medical science advances, doctors and surgeons often feel ... consider to be more cutting edge. Yet, when it comes ... treatment that stands out as the best solution in all ...
(Date:1/23/2015)... , Jan. 23, 2015  MedScope ( www.medscope.org ), ... nominated for a 2015 Connected World magazine ... Response System (mPERS), that can be used anywhere, anytime. ... partner.  In nominating MedScope, Landon ...
(Date:1/23/2015)... , Jan. 23, 2015  HyGreen, Inc., a leader ... and partnership with RCA Medical, a subsidiary of Ascendis ... . Each year, hundreds of millions of ... infections as organisms are transmitted from patient to patient ...
Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
... , , , , ... , , DES PLAINES, Ill., Sept. 10 ... program to support fresh and creative research ideas for solving the challenges of ... have been some significant scientific breakthroughs over the past decade resulting in better ...
... , EMERYVILLE, Calif., Sept. 10 ... http://www.novabaypharma.com ), a clinical stage company developing novel ... range of bacterial, viral and fungal infections, announced today the ... Aganocide(R) compound NVC-422 in impetigo. , , ...
Cached Medicine Technology:American Brain Tumor Association Calls for Discovery Research 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 3NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 4
(Date:1/22/2015)... Bradley, Illinois (PRWEB) January 22, 2015 Deer ... -- will host a Valentine’s Day Happy Hour from 3 p.m. ... located at 12500 Regency Parkway in Huntley, Illinois, serves adults with ... Happy Hour event will include Valentine's Day treats, games and sweetheart-themed ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on ... anniversary of the Supreme Court decision Roe v. Wade, which legalized ... the Roe vs. Wade decision and the fight to protect a ... City of West Hollywood Councilmember Abbe Land. “We need to continue ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 VogueQueen is a ... affordable prices and many designers are thrilled to have it ... business announces its new collection of prom dresses for the ... to drive the strategic vision and he focuses on continuing ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, ... dresses. View website of AngelWeddingDress.com to find ... wedding dresses online for a bridal party. AngelWeddingDress offers ... for them. Its maternity wedding dresses are specially designed ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... Central Government of India has now issued a list ... reference standards or grades that should be followed in ... list was issued after a number of reports claimed ... basis had developed adverse effects. ,The substances ...
... opt for mercy killing// in Netherlands. ,New ... may have the choice of mercy killing in Dutch. ... guidelines which is called as Groningen Protocol to be ... Society accepted that "in exceptional circumstances and under strict ...
... menopause that gets eliminated during the hormone replacement therapy// ... discontinued. ,Hormone replacement therapy is the treatment procedure ... also known as synthetic progesterone. At times the treatment ... surgical removal of their uterus. HRT is often used ...
... it helps if the donors// and the recipients sit in front ... research by the Cardiff University investigators it had come to light ... their donors as they feel they would personally like to ensure ... the donor’s health. ,The donors on the other hand had ...
... a potent narcotic medication for pain management// is under FDA ... were reported. The FDA says it is conducting an investigation ... unclear if the deaths are due to inappropriate use of ... product. ,Deaths and overdoses have occurred in patients using ...
... initiative a railway station – Ongole town in Andhra Pradesh ... not only broadcast arrival and departures of trains but also ... safe sex. Andhra Pradesh in India has high incidence of ... current generation is racing towards HIV/AIDS like mad. I witness ...
Cached Medicine News:
IDENTI-MATCH II is a combination of the IDENTI-MATCH Blood Recipient Identification System and an admitting band. It has been designed for those facilities using label-based patient ID systems....
Integrate RFID and bar code technology with the new DR1000 Dual RFID/Bar Code Reader by Precision Dynamics Corporation (PDC). It provides an easy migration from bar codes to RFID tags for healthcare ...
... Trax System includes real time ... active RFID, telemetery and choke-point ... intergrated infrastructure. Health Trax Standards-based ... people in in door and ...
... The Kisses tag is part of ... the Hugs system. The Kisses tag ... after it has been bonded with ... baby. he two tags remain electronically ...
Medicine Products: